The insulin-like growth factor (IGF) system plays an important role in regulating ovarian follicular development and steroidogenesis. IGF binding proteins (IGFBP) mostly inhibit IGF actions, and IGFBP proteolysis is a major mechanism for regulating IGF bioavailability. Pregnancyassociated plasma protein-A (PAPPA) is a secreted metalloprotease responsible for cleavage of IGFBP4 in the ovary. The aim of this study was to investigate whether PAPPA plays a role in regulating ovarian functions and female fertility by comparing the reproductive phenotype of wild-type (WT) mice with mice heterozygous or homozygous for a targeted Pappa gene deletion (heterozygous and PAPP-A knockout [KO] mice, respectively). When mated with WT males, PAPP-A KO females demonstrated an overall reduction in average litter size. PAPP-A KO mice had a reduced number of ovulated oocytes, lower serum estradiol levels following equine chorionic gonadotropin administration, lower serum progesterone levels after human chorionic gonadotropin injection, and reduced expression of ovarian steroidogenic enzyme genes, compared to WT controls. In PAPP-A KO mice, inhibitory IGFBP2, IGFBP3, and IGFBP4 ovarian gene expression was reduced postgonadotropin stimulation, suggesting some compensation within the ovarian IGF system. Expression levels of follicle-stimulating hormone receptor, luteinizing hormone receptor, and genes required for cumulus expansion were not affected. Analysis of preovulatory follicular fluid showed complete loss of IGFBP4 proteolytic activity in PAPP-A KO mice, demonstrating no compensation for loss of PAPPA proteolytic activity by other IGFBP proteases in vivo in the mouse ovary. Taken together, these data demonstrate an important role of PAPPA in modulating ovarian function and female fertility by control of the bioavailability of ovarian IGF.
INTRODUCTION
Pituitary gonadotropins and the intraovarian insulin-like growth factor (IGF) system are key modulators of ovarian follicle growth, selection, atresia, cellular differentiation, steroidogenesis, oocyte maturation, cumulus expansion, and follicle dynamics [1] . The IGF family is comprised of IGF peptides (IGF-I, IGF-II), IGF receptors, IGF binding proteins (IGFBPs), and IGFBP proteases. IGF peptides are mitogenic, differentiating survival factors that act primarily through the Type I IGF membrane tyrosine kinase receptor [2] . The type II receptor regulates IGF-II turnover [3] and has little signaling capacity [4] . IGFBPs have higher affinity for the IGFs than the receptors, and they mostly inhibit IGF action by peptide sequestration [5] [6] [7] . IGFBP proteases cleave IGFBPs, decreasing their affinities for the IGFs and increasing IGF peptide bioavailability [5] . In human ovary at the time of dominant follicle selection, IGF-II is increased in granulosa cells, IGFBPs are decreased, and the IGFBP4 protease is increased in the follicular antrum [8] [9] [10] [11] . The net result of this repertoire of IGF family expressions is to increase IGF bioavailability in order to act as a co-gonadotropin in stimulating granulosa steroidogenesis [1, 12] . In contrast, in atretic follicles, IGF2 levels are low, IGFBPs are increased, and the IGFBP4 protease is nearly undetectable [8, 9, 11] , resulting in limited IGF bioavailability and compromised follicle survival [1, 12] .
IGFBP4 is the main inhibitory IGFBP in the ovary, and the ovarian IGFBP4 protease has been identified as pregnancyassociated plasma protein-A (PAPPA) in humans [10, 13] and domestic animals [14, 15] . PAPPA expression in granulosa is increased by gonadotropins, and ovarian PAPPA is a marker of follicle selection and the corpus luteum [10, 13, 16, 17] . Recently, the development of Pappa knockout (KO) mice revealed a phenotype of viable, proportional dwarfs 60% the size of wild-type (WT) littermates [18] . However, the reproductive phenotype has not been characterized. The purpose of the current study was to examine the hypothesized reduced reproductive potential of the Pappa KO mouse (based on known functions of IGFs, IGFBPs, and IGFBP proteases) and to delineate a potential mechanism for any observed effects by analyzing ovarian expression of genes encoding steroidogenic enzymes after equine chorionic gonadotropin (eCG) priming and human chorionic gonadotropin (hCG) stimulation. Thus, herein, we report on the reproductive capability of the Pappa KO mouse and the steroidogeneic capacity of the Pappa KO mouse ovary. The data support a key role of the IGF system in folliculogenesis and steroidogenesis and underscore the importance of PAPPA in these processes and in female fertility.
MATERIALS AND METHODS

Targeted Disruption of the Pappa Gene in Mice
Generation of Pappa KO (Pappa tm1Cac /Pappa tm1Cac , hereafter PAPP-A KO) mice in a C57BL/6x129 background has been described [18] . The mice were housed and bred at Stanford University Research Animal Facility, and new breeding pairs were established in the Laboratory Animal Resources Center at the University of California, San Francisco, for further validation of some experiments. All animal protocols were approved by the Administrative Panel on Laboratory Animal Care at Stanford University and by the IACUC Panel at the University of California, San Francisco. All experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Genotyping
Mouse genomic DNA was isolated from tail tips using the DNeasy Tissue Kit (Qiagen, Valencia, CA). Genotyping was performed using a multiplex PCR reaction containing 13 HotStarTaq Master Mix (Qiagen), 1 ll DNA template, 0.4 lM common forward primer (5 0 -TAAGCAGGGGTGGGTCCTTT-3 0 ) annealing to the Pappa gene in immediate proximity to the Neo-gene insertion site, 0.3 lM Pappa reverse primer (5 0 -CACTCCTCAGCTTCGGCTTTCA-3 0 ), and 0.4 lM Neo reverse primer (5 0 -TCGCCTTCTATCGCCTTCTTG-3 0 ) in a final volume of 25 ll. PCR was carried out with an initial step of 948C at 15 min followed by 38 cycles of 948C for 30 sec, 608C for 30 sec, and 728C for 1 min. The PCR fragments were separated on a 2% agarose gel, and genotypes were determined according to band sizes, with a WT allele giving rise to a 306-bp band, and a Neo (i.e., a PAPP-A KO) allele giving rise to a 481-bp band.
Superovulation
Immature (20-to 22-day-old) female mice were primed with eCG (National Hormone and Peptide Program, NIDDK, Torrance, CA) for 47 h by i.p. injection (5 IU per mouse). Some mice also received i.p. injection with hCG (5 IU per mouse; National Hormone and Peptide Program, NIDDK, Torrance, CA). At various time points after gonadotropin treatments, mice were euthanized using cervical dislocation and weighed, and the ovaries were removed, weighed, flash frozen in liquid nitrogen, and stored at À808C. The ovaries were analyzed for gene expression and follicular fluid IGFBP-4 protease activity. To determine ovulatory capacity, cumulus oocyte complexes (COCs) were isolated from the oviducts 16 h after hCG injection in 22-and 42-day-old female mice and counted. Ovulation is expected to occur 12 h after hCG injection in this model.
Histology
Ovaries from 22-day-old unprimed mice, 22-day-old eCG-primed mice, and 22-day-old eCG-primed mice 8 h after hCG injection were fixed in Bouin solution overnight, paraffin embedded, sectioned at 5 lm, and stained with hemotoxylin and eosin (H&E). Photomicrographs were taken under a standard light microscope with a 43 objective lens. Histological analysis of folliculogenesis was carried out on ovaries from 22-day-old unprimed mice as described previously [19] . The presence of follicles at preantral, early antral, and mid-to large antral stages was surveyed in every third section, and only follicles with visible germinal vesicle were counted. Ovaries of three WT, four heterozygous (HET), and four PAPP-A KO mice were used for this analysis, and a 49, 54, and 75 sections of each WT, HET, and PAPP-A KO ovary, respectively, were surveyed. Two mice of each genotype were used for the assessment of ovarian responses to eCG and hCG stimulation. The dominances of large antral follicles in the ovarian cortex and follicles with expanded cumulus cells were considered to be normal responses to eCG and hCG,respectively.
Determination of Serum Steroid Hormone Levels
Using cardiac puncture, whole blood was collected from female mice at indicated times after hormone priming. The blood samples were allowed to clot for 1.5 h at room temperature and spun for 15 min at 1600 3 g, after which the serum was aspirated and stored at À208C. Levels of estradiol (E 2 ) and progesterone (P 4 ) in mouse serum were measured using the 3rd generation Estradiol DA RIA (DSL-39100) and Progesterone EIA (DSL-3400), respectively, obtained from Diagnostic Systems Laboratories, Inc. (Webster, TX). All serum samples were diluted 1:8 in PBS (for E 2 ) or 1:5 in Std A from the manufacturer (for P 4 ) and assayed in duplicate. Identical dilutions were performed for all samples analyzed to ensure the best possible comparability.
RNA Isolation
Frozen ovaries were mechanically homogenized in 600 ll RLT lysis buffer (RNeasy mini kit; Qiagen) with 1% b-mercaptoethanol using a hand-held Polytron homogenizer (Kinematica, Bohemia, NY). The resulting homogenate was further homogenized by spinning through a QIAshredder spin column (Qiagen). An equal volume of 70% EtOH was added to the lysate, and total RNA was isolated using the RNeasy mini kit. The RNA was eluted in a volume of 50 ul water and stored at À808C. RNA purity and concentration were assessed by optical density (OD) 260 and OD 280 measurements.
Reverse Transcription and Real-Time Quantitative PCR
Total RNA (2 lg) was reverse transcribed using the Omniscript RT Kit (Qiagen), 10 U of Ribonuclease Inhibitor (Invitrogen), a final concentration of 5 lM Oligo(dT) [12] [13] [14] [15] [16] [17] [18] (Invitrogen, Carlsbad, CA), and Random Primers (Invitrogen) in a 40-ll reaction. The reaction was performed at 378C for 1 h then 658C for 5 min, and subsequently diluted 1:10 with RNase-free water. The levels of mRNA encoding (a) the transporter and enzymes in the steroidogenic pathway (Star, Cyp11a1, Cyp19a1, Cyp17a1, Hsd17b1, Hsd17b3, Hsd3b1, and Hsd3b6), (b) the IGF system (Pappa, Igf1, Igf2, Igf1r, Igfbp1, Igfbp2, Igfbp3, Igfbp4, Igfbp5, and Igfbp6), (c) genes required for the cumulus expansion process (Has2, Ptgs2, and Tnfaip6), and (d) the luteinizing hormone (LH)/choriogonadotropin (CG) receptor (Lhcgr) and the follicle stimulating hormone (FSH) receptor (Fshr) were then assessed (primer sequences are shown in Table 1 ) by real-time quantitative PCR (QPCR) using the above cDNA as template. QPCR was performed on an Mx4000 Multiplex Quantitative PCR System (Stratagene, La Jolla, CA) by determining the threshold cycle values (CT). Each QPCR reaction contained 13 SYBR Green PCR Master Mix (Qiagen), 0.2 lM forward primer, 0.2 lM reverse primer, and 5 ll cDNA (diluted 103) in a total volume of 25 ll. The cycle conditions were an initial step of 948C for 15 min, 40 cycles of 948C for 15 sec, 608C for 30 sec, and 728C for 30 sec. Each sample was amplified in duplicate, and water blanks were included as controls. Data were collected and analyzed using Mx4000 v4.00 software as previously described [20] . For each gene, the amplification efficiency (E goi ) of the primer set was determined by performing QPCR using a dilution series of the cDNA as template.
The Rpl19 gene was used as a normalizer gene to correct for the total amount of RNA in each sample [21] [22] [23] . In addition, b-actin (Actb) and b2-microglobulin (B2m) were analyzed in a subset of samples to verify minimal variation between these normalizer genes and Rpl19 (data not shown). The ratio between the expression level of each gene of interest (goi) and Rpl19 (R goi/norm ) at the indicated time points for each genotype was determined by the equation:
The expression levels were determined relative to the average expression level for 22-day-old WT mice at the indicated time points for each gene, except for the cumulus expansion genes (Has2, Ptgs2, and Tnfaip6), where the WT level at the time of hCG injection was used as the reference. To avoid potential amplification of contaminating genomic DNA in the QPCR, all primer pairs were designed to anneal to different exons interspersed with at least one intron at the genomic level. In addition, the PCR products were analyzed on a 2% agarose gel to ensure that only one band of the expected size was present following the reaction.
Measurement of IGFBP4 Proteolytic Activity in Ovarian Follicular Fluid
Follicular fluid (FF) was collected 47 h after eCG injection. For each mouse, the ovaries were placed directly in 4-cm Petri dishes containing 50 ll 13 PBS. All follicles were punctured with a pair of 27-gauge needles, and the released FF was spun for 15 min at 350 3 g to remove remaining cellular debris. The diluted FF was stored at À208C. IGFBP4 proteolytic activity in FF was essentially performed as described [24] . In brief, 5 ll FF was incubated at room temperature for 24 h with purified [ 
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This paper 160 bp Forward
CGAGCCTTCTGCAACTATGAT
Reverse
GGCTATATCCCCGAAGATCTTT
Igf1r
This paper 158 bp Forward
AGCAAGTTCTTCGTTTCGTCA
Reverse
CTCCATCTCATCCTTGATGCT
Igfbp1
This paper 468 bp Forward
TGTACCAGAACCTGCTGCAC
Reverse
GGGTCCCCTCTAGTCTCCAG
Igfbp2
This paper 205 bp Forward
CGGGTACCTGTGAAAAGAGAC
Reverse
TGCTGTTCATTGACCTTCTCC
Igfbp3
This paper 477 bp Forward
ATTCCAAGTTCCATCCACTCC
Reverse
GTAGCCAGCTGCTGATCATGT
Igfbp4
This paper 444 bp Forward
GAGAAGCCCCTGCGTACAT
Reverse
AGGAAGCTTCACCCCTGTCT
Igfbp5
This paper 267 bp Forward
TTGCCTCAACGAAAAGAGCTA
Reverse
TGTTCGGATTCCTGTCTCATC
Igfbp6
This paper 303 bp Forward
TCTCGTGACACAAACCACAGA
Reverse
TCCTTGACCATCTGGAGACAC
Igf1
This paper 145 bp Forward
CTGGTGGATGCTCTTCAGTTC
Reverse
CCAGTCTCCTCAGATCACAGC
Igf2
This [25] . Generation of recombinant human PAPPA has previously been described [26] .
Statistical Analysis
All data are presented as mean 6 SEM. Statistical analyses were performed using GraphPad Prism version 4 for windows (GraphPad Software, Inc., La Jolla, CA). Litter sizes and ovary:body weight ratios were compared with oneway ANOVA, followed by Dunnett multiple-comparison post hoc test. For the number of ovulated COCs, the data from WT and HET mice were pooled and compared to PAPP-A KOs for 22-and 42-day-old mice using the Student unpaired t-test after log transformation. All gene expression comparisons between genotypes were made with one-way ANOVA using log-transformed fold-change data at individual time points, followed by Dunnett multiplecomparison post hoc test. Comparisons of gene expression levels in gonadotropin-stimulated versus unstimulated mice were done with one-way ANOVA followed by Dunnett multiple-comparisons post hoc test.
RESULTS
PAPP-A KO Female Mice Have Reduced Litter Size and Reduced Ovulatory Capacity
When mated with WT males, the average size of litters produced by PAPP-A KO females (5.1 6 0.7) was markedly and significantly (P , 0.01) lower than that produced by WT (8.7 6 0.9) or HET (8.1 6 0.4) female mice (Fig. 1A) . Furthermore, when female mice underwent superovulation cycles at 22 and 42 days of age, PAPP-A KO mice ovulated a significantly (P , 0.05) reduced number of COCs, compared to WT or HET mice (50.0 6 4.0 vs. 71.1 6 7.3 and 10.7 6 3.3 vs. 25.5 6 3.0, respectively; Fig. 1B ). As previously published [18] , the PAPP-A KO mice were smaller than WT or HET littermates (8.8 6 0.3g vs. 14.4 6 0.3g and 13.1 6 0.3g, respectively, at 24 days of age), and they demonstrated proportionally smaller ovary size in unstimulated and eCGprimed mice. Upon hCG injection, an apparent lack of ovarian weight gain in the PAPP-A KO mice demonstrated a diminished response to hCG (Fig. 1C) , resulting in a significantly lower ovary:body weight ratio in the PAPP-A KO compared to HET or WT mice at 8 h after hCG (Fig. 1D ). The ovary:body weight ratio is a measure of the specific ovary response to the hormonal stimulation, which is directly comparable between genotypes of different sizes. Collectively, these data suggest that mice lacking a functional Pappa gene have reduced fertility potential compared to HET or WT mice. Although smaller ovaries were observed in the PAPP-A KO mice, morphologically, all follicle stages were present, and no gross difference, except the proportionally smaller size, was Ovaries from 22-day-old eCG-primed mice 8 h after hCG injection were fixed overnight in Bouin solution, paraffin embedded, sectioned at 5 lm, and stained with H&E. One intact ovary cross section is seen in each micrograph.
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found between PAPP-A KO and WT or HET ovaries in 22-day-old mice before and after eCG priming (not shown). Cumulus of mutant mice underwent normal expansion, as determined by the formation of a normal matrix surrounding the oocyte 8 h after hCG administration (Fig. 1E ).
Serum Steroid Hormone Levels
As an initial approach to determine the possible causes of the reduced fertility of PAPP-A KO mice, steroid hormone concentrations were measured in serum from 22-day-old female mice 47 h after eCG priming (0 h hCG), or 4, 8, and 24 h after hCG injection (given 47 h after the initial eCG priming). As evident from Figure 2A , serum E 2 levels of all genotypes were decreased at 4 h after hCG injection and were decreased further over time, reaching an almost undetectable level at 24 h for WT and HET mice. Levels of P 4 (Fig. 2B) were dramatically increased at 4 h after hCG administration, then leveled off at 8 and 24 h, yet at a significantly higher level than at the time of hCG injection (P , 0.01 for all time points). The patterns of serum steroid concentrations were compatible with the shift from E 2 to P 4 production of the luteinizing ovarian granulosa cells following the LH peak in an unstimulated cycle and were similar to our previously published studies [23] . The E 2 levels in PAPP-A KO mice were significantly lower (P , 0.05) than that in WT mice after eCG stimulation (0 h hCG; WT ¼ 132.5 6 14.9, PAPP-A KO ¼ 83.5 6 23.0 pg/ml; Fig. 2A ). In contrast, serum E 2 levels in PAPP-A KO mice were significantly higher than in WT mice at 24 h after hCG injection (WT ¼ 7.1 6 0.3, PAPP-A KO ¼ 10.0 6 1.2 pg/ml; P , 0.05) and showed a tendency to be higher at 8 h without reaching statistical significance (WT ¼ 16.6 6 4.1, PAPP-A KO ¼ 21.9 6 13.4 pg/ml). It proved essential to use an assay of high sensitivity (see Materials and Methods) to determine the serum E 2 levels. Significant reductions in the P 4 levels in PAPP-A KO vs. WT mice were found (Fig. 2B ) at 8 h (P , 0.01) and 24 h (P , 0.05) after hCG injection (8 h: WT ¼ 44.4 6 3.9, PAPP-A KO ¼ 20.5 6 3.1 ng/ml; 24 h: WT ¼ 34.7 6 3.1, PAPP-A KO ¼ 19.2 6 5.4 ng/ml). At the time of hCG injection, the mean P 4 level in the PAPP-A KO mice was also lower than in the WT mice without reaching statistical significance (WT ¼ 11.3 6 1.9, PAPP-A KO ¼ 7.6 6 2.2 ng/ml).
Ovarian mRNA Levels of Genes Encoding Proteins Involved in the Steroidogenic Pathway
To delineate the potential cause of the altered levels of steroid hormones, we investigated ovarian levels of transcripts 
COMPROMISED FERTILITY IN PAPP-A NULL MICE
encoding enzymes in the steroidogenic pathway using real-time QPCR. Figure 3 shows the expression level of genes encoding enzymes in the pathway of P 4 synthesis: steroidogenic acute regulatory protein (Star; Fig. 3A) , cytochrome P450 side chain cleavage (Cyp11a1; Fig. 3B ), and 3b-hydroxysteroid dehydrogenase type 1(Hsd3b1; Fig. 3C ). Figure 4 shows the expression level of genes encoding enzymes converting P 4 to E 2 : P450 17a -hydroxylase/C17-20 lyase (Cyp17a1; Fig. 4A ), 17b-hydroxysteroid dehydrogenase type 1 (Hsd17b1; Fig. 4B ), and cytochrome P450 aromatase (Cyp19a1; Fig. 4C ). When comparing the observed expression levels in WT mice with the publicly available microarray data in the Rat Ovarian Gene Database (rOGED), which contains rat ovarian gene expression data from the time points of 0, 12, and 48 h after eCG priming and 6 and 12 h following hCG stimulation [27] , highly similar expression profiles were observed for all genes in the steroidogenic pathway.
Overall, in comparing the PAPP-A KO and WT expression levels, these data suggest a delayed shutdown of E 2 -synthesizing genes after hCG administration. Furthermore, since the PAPP-A KO mice appear to have a blunted response to hCG stimulation, we determined the time-dependent expression levels of the FSH and LH/CG receptors following eCG and hCG administration. No significant differences in the levels of Fshr or Lhcgr mRNA were observed between the PAPP-A KO and the WT mice at any of the time points investigated (data not shown).
Ovarian Pappa mRNA Levels
The mRNA level for Pappa is significantly increased in WT ovary after eCG stimulation in a time-dependent manner (P , 0.05 at 2 h, P , 0.01 for all other time points; Fig. 5A ), confirming previous findings [16] . No further stimulation was observed after hCG administration, and, in fact, levels of WT Pappa mRNA decreased after hCG (Fig. 5A) . No significant differences were observed between WT and PAPP-A KO or HET mice, except for a lower Pappa mRNA level in the untreated PAPP-A KO mouse. The targeted deletion of the Pappa gene in the PAPP-A KO mouse did not remove the promotor or most of the mRNA, but transcription resulted in a truncated, nonfunctional mRNA that can be detected by the primers used in the QPCR assay for Pappa.
PAPPA Is the Only IGFBP4 Protease in Murine Ovaries
To determine whether IGFBP4 proteolytic activity was indeed absent in the ovarian follicular compartment in PAPP-A KO mice, ovaries were harvested from WT and PAPP-A KO mice stimulated 47 h prior with eCG. Follicular fluid was obtained from large antral follicles and analyzed for IGFBP4 proteolytic activity, with or without added IGF-II (Fig. 5B) . As seen in lanes a and b, the recombinant PAPPA control shows an IGF-dependent IGFBP4 proteolytic activity, consistent with the known IGF2 (IGF-II)-dependence of this enzyme [28] . No cleaved IGFBP4 fragment was detected in the mock group treated only with control medium (negative control, lane g). Lanes c and d show that the WT ovarian follicular fluid contained high levels of IGFBP4 proteolytic activity that is enhanced by IGF addition. In contrast, lanes e and f reveal a total absence of IGFBP4 proteolytic activity in follicular fluid from PAKO mice, with or without addition of IGF2. Interestingly, WT follicular fluid likely (and expectedly) contained some bio-available IGF, since the observed proteolytic activity was not totally dependent on addition of exogenous IGF. These results demonstrate unequivocally that no other protease can substitute for PAPPA IGFBP4 proteolytic activity in the murine ovarian compartment. Furthermore, the total absence of IGFBP4 proteolysis in PAPP-A KO FF strongly suggests that the observed reduction of reproductive capacity of the PAPP-A KO female mouse is a consequence of reduced IGF availability in the follicular compartment.
Ovarian mRNA Levels of Genes in the IGF-System
No increase in the levels of Igf1 or Igfr1 mRNA was detected in WT mouse ovaries in response to gonadotropin stimulation, which is consistent with the expression data in rOGED [27] , and no significant differences in the Igf1 or Igfr1 mRNA levels between WT and HET or PAPP-A KO mouse ovaries were found for any of the time points investigated (data not shown). Lower expression levels of Igfbp2, Igfbp3, and Igfbp4 at certain time points after eCG and hCG stimulation were observed in PAPP-A KO vs. WT (Fig. 6, A-C) , and no significant differences in the expression levels for Igfbp5 and Igfbp6 were observed at any of the studied time points during the stimulated cycle (data not shown). Igfbp1 and Igf2 expression levels were too low to be detected (all genotypes, data not shown).
Ovarian mRNA Levels of Genes Required for Cumulus Expansion
Because there is a significant reduction in the number of ovulated COCs in PAPP-A KO mice, we investigated the expression levels, following hCG injection, of genes previously shown to be required for the cumulus expansion process (Has2, Ptgs2, and Tnfaip6 [29] ). As seen in Figure 7 , all three genes show a dramatic and transient increase in transcript levels at 4 h, with a rapid decline by 8 h in PAPP-A KO, HET, and WT ovaries without significant differences among the genotypes. These data and the observation of formation of normal extracellular matrix surrounding COCs indicate that timing of the cumulus expansion process is normal in PAPP-A KO ovaries and is not the cause for reduced ovulation rate and subfertility in these mice.
DISCUSSION
The intraovarian IGF system plays an important role in augmenting gonadotropin actions on granulosa and theca and also during dominant follicle selection and oocyte maturation [1] . Furthermore, the IGFBP-4 protease in the ovary, PAPP-A, is a marker of follicle selection and the corpus luteum [10, 13] . Data in the current study demonstrate that PAPP-A is essential for normal fertility, based on observations in the PAPP-A KO mouse of lower litter size, lower numbers of oocytes ovulated upon gonadotropin stimulation, and lower E 2 and P 4 levels during superovulation cycles. Of interest, and unexpectedly, the phenotype is not one of sterility but rather reduced fecundity (lower litter size), likely due to decreased numbers of ovulated oocytes in natural cycles, with genes governing cumulus expansion appropriately expressed in the PAPP-A KO mouse as in WT and HET. With decreased intrafollicular IGFBP-4 proteolysis, IGF peptide bioavailability is presumed to be decreased within the PAPP-A KO ovary, and this phenotype is consistent with this process. However, an implantation defect cannot be ruled out, especially in view of significantly lower levels of E 2 after eCG treatment and of P 4 after hCG treatment in PAPP-A KO vs. WT mice, although gestational age of term pregnancy was not reduced. It is noteworthy, however, that in contrast to the very high primate placental PAPPA expression level, the murine placenta demonstrates a remarkably low level of PAPPA expression [30, 31] . The PAPP-A KO mouse has a remarkably different phenotype compared to the Igf1-and Igf1r-null mice, which have a more extreme phenotype with the absence of IGFI and IGF type I receptor signaling. Igf1-null females are infertile due to several reasons [32] , including (a) diminished sex drive in both sexes in adulthood, (b) diminished lordosis in adult females, (c) E 2 synthesis is decreased about 50%, (d) ovarian weight is significantly diminished, (e) formation of small Graafian follicles is rare, (f) some antral follicle granulosa exhibit features of early atresia, (g) the thecal layers are not well delineated, (h) there is no evidence of ovulation, and (i) animals display hypoplastic myometrium and dramatically reduced uterine size. These are in marked contrast to the PAPP-A KO mouse whose follicles have normal histology and where uterine size is not appreciably diminished (data not shown). Furthermore, FSH receptor expression is decreased in Igf1-null mice, and Igf1-and Fshr-null animals similarly have arrested follicular development [33] . Fshr-null animals also exhibit female infertility due to a block in folliculogenesis that occurs prior to antral follicle formation [34] , lack of estrous cyclicity, decreased ovarian and uterine mass, and no evidence of corpora lutea. In addition, serum levels of FSH and LH are significantly elevated, and inhibin A and B levels are undetectable [35] . Of interest, in the PAPP-A KO mouse ovary, Fshr mRNA level was not different compared to WT ovary. This is not unexpected, since the impact of the Pappanull mutation on ovarian function is observed herein at a much later stage than in the Igf1-or Fshr-null mutations. As discussed below, PAPPA appears to be a moderator or an accelerator of IGF bioavailability, and the phenotype is not expected to be as dramatic as a total removal of IGFI or the FSHR, and indeed is not, as described herein.
With regard to the PAPP-A KO mouse, lower circulating levels of E 2 were observed after eCG stimulation. However, E 2 levels were significantly higher after 24 h of hCG administration and showed a tendency to be elevated at 8 h, although this did not reach significance. This could be the result of a delayed response to hCG of E 2 synthesizing genes (Cyp19a1 and Cyp17a1), such that the switch from E 2 production to P 4 of granulosa cells may be slightly delayed due to decreased bioavailability of IGF in the PAPP-A KO ovary that may be critical for ''correct'' activation of the appropriate pathways essential for the switch of steroidogenic enzyme gene expression [23] . We have previously shown that activation of the MAPK-pathway (by LH) triggers a shift in granulosa steroidogenic output from E 2 to P 4 (Cyp19a1 down-regulated, Star and Cyp11a1 up-regulated [23] ), and this has also recently been elegantly demonstrated in vivo by Fan et al. [36] . EGFlike growth factors are important ovarian components upstream of the MAPK pathway [37] , and whether the EGF network is affected in the PAPP-A KO will require further experiments. We do not find this likely, however, since the expression level of genes involved in cumulus expansion (Has2, Ptgs2, and Tnfai6p) are not affected. Instead, we speculate that costimulation of the MAPK pathway by IGF may be needed for an optimal steroidogenic shift, based on the apparent delay in luteinization in the PAPP-A KO mouse, which was indicated by delayed shutdown of aromatase (evident at 8 h hCG) and higher E 2 levels at 24 h hCG. Experimental evidence to support 1136 this conjecture is not yet available and is worthy of further evaluation.
The PAPP-A KO mouse demonstrates a disruption of the steroidogenic pathway that becomes manifest after hCG stimulation. Diminished expression of enzymes in the ratelimiting step of steroid hormone biosynthesis and enzymes important in P 4 synthesis and subsequent throughput for E 2 biosynthesis, including Star and Cyp11a1, likely results in lower E 2 and P 4 circulating levels, although we cannot exclude the possibility of a decrease in antral follicle numbers or changes in posttranscriptional regulation. Furthermore, interestingly, during eCG treatment, expression of enzymes important for E 2 biosynthesis (Cyp17a1, Cyp19a1, and Hsd17b1) were equivalent among PAPP-A KO, HET, and WT mice; however, all three enzymes were decreased in the PAPP-A KO ovary within 4 h after hCG administration, suggesting compromised LH responsiveness. Our previous study in human ovary [10] and studies in human and rodent ovary by Adashi and colleagues [16, 17] revealed high expression of PAPPA in the corpus luteum. The current study suggests that PAPPA is an important regulator of triggering luteinization and steroidogenesis in the corpus luteum in the mouse, and that a reduction in LH/CG receptor is not a mechanism for the observed diminution of steroid hormone biosynthesis. Alterations in receptor responsiveness and postreceptor signaling, however, cannot be ruled out.
The fact that we observe fewer ovulated oocytes in the superstimulated PAPP-A KO animals does not necessarily explain the changes seen in serum steroid levels or the altered expression levels of steroidogenic enzymes, since these measurements are inherently normalized to the smaller size of the PAPP-A KO animals (steroid levels per volume serum and expression levels to the total ovary mRNA population). Also, an effect of fewer mature follicles could not explain the simultaneous higher level of E 2 -synthesizing genes and lower level of P 4 -synthesizing genes in PAPP-A KO compared to WT mice, observed at 8 h hCG. Hence, we conclude that deletion of functional PAPPA has a direct impact on steroidogenesis. However, the mechanism underlying why fewer ovulated oocytes in stimulated PAPP-A KO animals occurs is currently not well understood and is worthy of further investigation.
The current study also unequivocally demonstrates that PAPPA is the IGFBP4 protease in mouse ovarian follicular fluid, without compensation from other proteases. Furthermore, we demonstrate that PAPPA expression in ovary is dramatically regulated (increased) by eCG. With regard to IGF, IGFBP, and IGFR expression, we found our results to be consistent with the rOGED array data [27] .
Furthermore, interestingly, the rOGED database [27] reveals a very tight correlation between total ovary mRNA levels and that of the isolated compartment (theca or granulosa) with the predominant expression for each particular gene of interest, following gonadotropin stimulation. Also, Pappa mRNA is primarily expressed in the granulosa compartment in the murine ovary [16] , and Matsui et al. [38] demonstrated that the increase in rat Pappa mRNA levels following eCG stimulation was the same for whole ovary and isolated granulosa cells, suggesting that the whole ovary may reflect compartmental expression of PAPPA, as in the studies herein. While PAPPA is exclusively a granulosa product in rodent and human ovary, interestingly, in isolated small and large bovine granulosa and theca cell cultures, Aad et al. [39] found that insulin with or without LH decreased (P , 0.05) Pappa mRNA. Furthermore, they found that E2 alone decreased Pappa mRNA levels and amplified insulin-induced inhibition of Pappa mRNA abundance in large theca cells. In the bovine model, it has been concluded that regulation of Pappa mRNA expression differs in these cell types [39] . Further evaluation of Pappa regulation in ovarian cell cultures from murine and human ovaries would be of value in comparing species differences and control of this important regulator of IGF action in the ovary.
Taken together, the data presented herein suggest that the phenotype of lowered fertility in the PAPP-A KO mouse is due to lower (local) IGF bioavailability in the ovary. When extending the analysis to include ovarian expression of other IGFBPs, we observed a possible compensation in the PAPP-A KO mouse, in that the expression of IGFBP2, 3, and 4 was reduced vs. WT at certain time points during an induced superovulation cycle. This strongly suggests that IGF bioavailability is crucial for optimal gonadotropin-induced steroidogenesis, and further suggests that fertility is rescued by compensatory expression of IGF-system components (e.g., lower IGFBP2/3/4). Another potential mechanism of compensation could be an increase in other IGFBP proteolytic enzymes. The data presented herein demonstrate, however, that this is not the case for IGFBP4 proteolysis.
Finally, IGFBP protease activity is a key regulatory process for IGF action [5, 40] in a variety of tissues and fluids, and as PAPPA is investigated in more and more systems, it is increasingly apparent that it is a key modulator of IGF activity. In the PAPP-A KO mouse, in addition to the delay in the switch from E 2 to P 4 production of granulosa after hCG treatment observed herein, delayed development of the fetus, delayed wound healing, and delayed healing of bone fractures have been observed [18, 41, 42] , underscoring a common delay or reduction in IGF-assisted physiological processes in this model. An important pursuit in human ovarian physiology is to determine the function of PAPPA in the corpus luteum and whether there is a role for compromised PAPPA activity in follicles resistant to gonadotropin stimulation and in the setting of compromised corpus luteum production of P 4 in some women with infertility and luteal insufficiency. This is worthy of further investigation, as IGFs and regulation of their actions are key to ovarian follicle development and function in women.
